Osaka, Japan

Masahiko Miyashiro



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Masahiko Miyashiro: A Pioneer in Melanocortin Receptor Research**

Introduction

Masahiko Miyashiro is a prominent inventor based in Osaka, Japan, known for his groundbreaking work in the field of pharmaceuticals. With a keen focus on developing innovative compounds, he has made significant contributions to medical research and therapeutic applications.

Latest Patents

Miyashiro holds a patented invention titled "Pyrrolidine compound and application as melanocortin receptor agonist." This novel pyrrolidine compound demonstrates agonist activity at melanocortin receptors, offering potential pharmacological benefits. The patent details a pyrrolidine derivative characterized by various functional groups, indicating its versatility and potential for pharmaceutical development.

Career Highlights

Miyashiro is affiliated with Mitsubishi Tanabe Pharma Corporation, where he applies his expertise in medicinal chemistry and drug development. His work greatly contributes to advancing treatments in areas such as obesity, diabetes, and other metabolic conditions linked to melanocortin receptors.

Collaborations

Throughout his career, Masahiko Miyashiro has collaborated with esteemed colleagues such as Yasuo Yamamoto and Atsushi Sato. Together, they have engaged in extensive research efforts to explore the therapeutic potentials of their innovations, fostering an environment of creativity and scientific inquiry.

Conclusion

With his inventive spirit and dedication to pharmaceutical research, Masahiko Miyashiro continues to impact the medical field. His patented work on pyrrolidine compounds highlights the importance of innovation in developing new therapeutic options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…